CA2531261A1 - Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria - Google Patents

Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria Download PDF

Info

Publication number
CA2531261A1
CA2531261A1 CA002531261A CA2531261A CA2531261A1 CA 2531261 A1 CA2531261 A1 CA 2531261A1 CA 002531261 A CA002531261 A CA 002531261A CA 2531261 A CA2531261 A CA 2531261A CA 2531261 A1 CA2531261 A1 CA 2531261A1
Authority
CA
Canada
Prior art keywords
gram positive
bacteria
killed
cells
positive bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002531261A
Other languages
English (en)
French (fr)
Inventor
Gilles Marchal
Micheline Lagranderie
Muhammad Abolhassani
Herve Bercovier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to CA002531261A priority Critical patent/CA2531261A1/en
Priority to MX2008008157A priority patent/MX2008008157A/es
Priority to EP06848694A priority patent/EP1971352A2/en
Priority to AU2006327761A priority patent/AU2006327761A1/en
Priority to CA002571886A priority patent/CA2571886A1/en
Priority to PCT/IB2006/004133 priority patent/WO2007072230A2/en
Priority to JP2008546689A priority patent/JP2009520810A/ja
Priority to KR1020087017840A priority patent/KR20080092384A/ko
Priority to US12/158,827 priority patent/US20090280146A1/en
Priority to CNA2006800532346A priority patent/CN101384270A/zh
Priority to CA002632839A priority patent/CA2632839A1/en
Publication of CA2531261A1 publication Critical patent/CA2531261A1/en
Priority to IL192048A priority patent/IL192048A0/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32—Mycobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002531261A 2005-12-21 2005-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria Abandoned CA2531261A1 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
CA002531261A CA2531261A1 (en) 2005-12-21 2005-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
PCT/IB2006/004133 WO2007072230A2 (en) 2005-12-21 2006-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
EP06848694A EP1971352A2 (en) 2005-12-21 2006-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
AU2006327761A AU2006327761A1 (en) 2005-12-21 2006-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
CA002571886A CA2571886A1 (en) 2005-12-21 2006-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
MX2008008157A MX2008008157A (es) 2005-12-21 2006-12-21 Control de sindromes inflamatorios intestinales con una preparacion de bacterias exterminadas o no infecciosas.
JP2008546689A JP2009520810A (ja) 2005-12-21 2006-12-21 死滅又は非感染性細菌の調製物を用いる腸炎症性症候群の管理
KR1020087017840A KR20080092384A (ko) 2005-12-21 2006-12-21 사멸 또는 비감염성 박테리아 제제를 사용한염증성장증후군의 조절
US12/158,827 US20090280146A1 (en) 2005-12-21 2006-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
CNA2006800532346A CN101384270A (zh) 2005-12-21 2006-12-21 用灭活的或非感染性的细菌制备物控制肠道炎症综合征
CA002632839A CA2632839A1 (en) 2005-12-21 2006-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
IL192048A IL192048A0 (en) 2005-12-21 2008-06-10 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002531261A CA2531261A1 (en) 2005-12-21 2005-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria

Publications (1)

Publication Number Publication Date
CA2531261A1 true CA2531261A1 (en) 2007-06-21

Family

ID=38175409

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002531261A Abandoned CA2531261A1 (en) 2005-12-21 2005-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
CA002632839A Abandoned CA2632839A1 (en) 2005-12-21 2006-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002632839A Abandoned CA2632839A1 (en) 2005-12-21 2006-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria

Country Status (10)

Country Link
US (1) US20090280146A1 (https=)
EP (1) EP1971352A2 (https=)
JP (1) JP2009520810A (https=)
KR (1) KR20080092384A (https=)
CN (1) CN101384270A (https=)
AU (1) AU2006327761A1 (https=)
CA (2) CA2531261A1 (https=)
IL (1) IL192048A0 (https=)
MX (1) MX2008008157A (https=)
WO (1) WO2007072230A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2087898A1 (en) * 2008-02-06 2009-08-12 Institut Pasteur A preparation of mycobacterium bovis BCG killed by extended freeze drying (EFD) for treating rheumatoid arthritis
CA2629057A1 (en) * 2008-04-14 2009-10-14 Institut Pasteur Control of diseases associated with decrease of t-regulatory cells with a preparation of extended freeze-dried killed bacteria
EP2292260A1 (en) 2009-08-13 2011-03-09 Institut Pasteur Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis
NZ702796A (en) * 2010-07-26 2017-03-31 Qu Biologics Inc Immunogenic anti-inflammatory compositions
WO2013004069A1 (zh) * 2011-07-05 2013-01-10 苏州科景生物医药科技有限公司 沙门氏菌鞭毛蛋白衍生物在制备防治炎症性肠病药物中的应用
US9886742B2 (en) 2016-03-17 2018-02-06 Google Llc Electro-optic beam steering for super-resolution/lightfield imagery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR012304A1 (es) * 1997-04-01 2000-10-18 Borody Thomas J Composiciones y metodos para el tratamiento de enfermedades intestinales inflamatorias y el uso de dicha composicion para preparar medicamentos paradichos tratamientos.
WO1998047520A1 (en) * 1997-04-24 1998-10-29 Lovelace Respiratory Research Institute Prevention and treatment of allergic disease by targeted development of protective t-helper lymphocyte immunity
AUPQ776100A0 (en) * 2000-05-26 2000-06-15 Australian National University, The Synthetic molecules and uses therefor
GB0106987D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeuitic agent
EP2316466B1 (en) * 2001-12-11 2013-08-21 Institut Pasteur Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
JP2005531289A (ja) * 2002-02-15 2005-10-20 アゲルプ ファーマ ゲーエムベーハー Ｓ．ａｕｒｅｕｓエンテロトキシンＢ由来の免疫調節ペプチド

Also Published As

Publication number Publication date
CN101384270A (zh) 2009-03-11
IL192048A0 (en) 2009-02-11
WO2007072230A3 (en) 2007-11-22
AU2006327761A1 (en) 2007-06-28
CA2632839A1 (en) 2007-06-28
WO2007072230A2 (en) 2007-06-28
KR20080092384A (ko) 2008-10-15
EP1971352A2 (en) 2008-09-24
MX2008008157A (es) 2008-09-24
JP2009520810A (ja) 2009-05-28
US20090280146A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
US20220257668A1 (en) Compositions comprising bacterial strains
JP7497433B2 (ja) ラクトバチルス・パラカゼイｋ５６の腸管炎症の緩和における新規な用途
EP3204024B1 (en) Compositions comprising bacterial strains
EP3240554B1 (en) Blautia stercosis and wexlerae for use in treating inflammatory and autoimmune diseases
EP3369425B1 (en) Compositions comprising bacterial strains
US7871627B2 (en) Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation
CN101138573A (zh) 酪酸梭菌、凝结芽孢杆菌制备治疗炎症性肠病药物中的应用
WO2025010811A1 (zh) 副干酪乳杆菌lc86在制备用于预防、缓解或治疗与衰老相关的肌肉萎缩的产品中的应用
CN110151771B (zh) 一种用于结肠炎修复的高流变性25-羟基维生素d3制剂
CA2531261A1 (en) Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
CN114699424B (zh) 脆弱拟杆菌两性离子荚膜多糖或/和改性的两性离子荚膜多糖的新应用
CN119752686A (zh) 一株可缓解及预防变应性鼻炎的长双歧杆菌婴儿亚种及其应用
US20250009812A1 (en) Use of bacteroides fragilis in prevention and treatment of cancer-related diarrhea
CN118497046A (zh) 一种提升肠道免疫力的益生菌剂及其应用
US20240335484A1 (en) Postbiotic
JP2004262773A (ja) 免疫機能改善を目的としたビフィズス菌製剤
CA2571886A1 (en) Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
CN116942685B (zh) 酸性羊乳寡糖组合物在制备抗过敏药物或食物中的应用
TWI878748B (zh) 乳酸菌組用於預防或治療nsaid引發的胃潰瘍之用途
Igwe et al. Pathology of experimental Salmonella gallinarum infection in turkeys (Meleagris gallopavo).
US20040247622A1 (en) Methods and compounds for the treatment of immunologically-mediated diseases using Mycobacterium vaccae
CN121065051A (zh) 一株改善腹胀、腹泻的短双歧杆菌及其应用
CN121931012A (en) Bacterial strain for improving skin diseases and product and application thereof
EP4525897A1 (en) Lachnospiraceae spp and ruminococcus lactaris strains for the treatment and prevention of alzheimer's disease and aging
HK1260125B (en) Compositions comprising bacterial strains

Legal Events

Date Code Title Description
FZDE Discontinued